Unbiased AI-powered news
2 stories related to this topic, newest first.
Nbc NewsDoctors and patients have reported difficulties obtaining certain doses of estrogen patches used in hormone replacement therapy. The FDA removed a black box warning from such therapies in November 2025 and has not listed any estrogen patches on its official drug shortage list. Mu…
Substrate placeholder — needs reviewThe U.S. Food and Drug Administration withdrew approval for a GlaxoSmithKline drug previously promoted by the Trump administration for autism treatment. In India, generic versions of GLP-1 drugs are entering the obesity treatment market. A shortage of estrogen patches used for me…